位置:首页 > 蛋白库 > RG1_RAUSE
RG1_RAUSE
ID   RG1_RAUSE               Reviewed;         540 AA.
AC   Q9SPP9;
DT   11-DEC-2013, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   03-AUG-2022, entry version 95.
DE   RecName: Full=Raucaffricine-O-beta-D-glucosidase;
DE            Short=Raucaffricine beta-glucosidase;
DE            Short=RsRG;
DE            EC=3.2.1.125;
DE   AltName: Full=Vomilenine glucosyltransferase;
DE            Short=RsVGT;
DE            EC=2.4.1.219;
GN   Name=RG; Synonyms=VGT;
OS   Rauvolfia serpentina (Serpentine wood) (Ophioxylon serpentinum).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   asterids; lamiids; Gentianales; Apocynaceae; Rauvolfioideae; Vinceae;
OC   Rauvolfiinae; Rauvolfia.
OX   NCBI_TaxID=4060;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 80-111; 319-326; 403-408;
RP   410-425 AND 428-438, FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RC   STRAIN=BENTH. ex KURZ; TISSUE=Protoplast;
RX   PubMed=10975500; DOI=10.1016/s0031-9422(00)00175-8;
RA   Warzecha H., Gerasimenko I., Kutchan T.M., Stoeckigt J.;
RT   "Molecular cloning and functional bacterial expression of a plant
RT   glucosidase specifically involved in alkaloid biosynthesis.";
RL   Phytochemistry 54:657-666(2000).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 1-513 IN COMPLEX WITH SUBSTRATE,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF GLU-186; THR-189;
RP   HIS-193; TYR-200; SER-390; TRP-392; GLU-420; GLU-476 AND PHE-485.
RX   PubMed=22004291; DOI=10.1021/cb200267w;
RA   Xia L., Ruppert M., Wang M., Panjikar S., Lin H., Rajendran C.,
RA   Barleben L., Stoeckigt J.;
RT   "Structures of alkaloid biosynthetic glucosidases decode substrate
RT   specificity.";
RL   ACS Chem. Biol. 7:226-234(2012).
CC   -!- FUNCTION: Glucosidase specifically involved in alkaloid biosynthesis
CC       leading to the accumulation of several alkaloids, including ajmaline,
CC       an important plant-derived pharmaceutical used in the treatment of
CC       heart disorders. {ECO:0000269|PubMed:10975500}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + raucaffricine = D-glucose + vomilenine;
CC         Xref=Rhea:RHEA:14557, ChEBI:CHEBI:4167, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:16408, ChEBI:CHEBI:17400; EC=3.2.1.125;
CC         Evidence={ECO:0000269|PubMed:10975500};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=UDP-alpha-D-glucose + vomilenine = H(+) + raucaffricine + UDP;
CC         Xref=Rhea:RHEA:19385, ChEBI:CHEBI:15378, ChEBI:CHEBI:16408,
CC         ChEBI:CHEBI:17400, ChEBI:CHEBI:58223, ChEBI:CHEBI:58885;
CC         EC=2.4.1.219; Evidence={ECO:0000269|PubMed:10975500};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.3 mM for raucaffricine (at pH 5 and 28 degrees Celsius)
CC         {ECO:0000269|PubMed:10975500, ECO:0000269|PubMed:22004291};
CC         KM=1.8 mM for strictosidine (at pH 5 and 28 degrees Celsius)
CC         {ECO:0000269|PubMed:10975500, ECO:0000269|PubMed:22004291};
CC         Vmax=0.5 nmol/sec/ug enzyme with raucaffricine as substrate (at pH 5
CC         and 28 degrees Celsius) {ECO:0000269|PubMed:10975500,
CC         ECO:0000269|PubMed:22004291};
CC         Vmax=2.6 pmol/sec/ug enzyme with strictosidine as substrate (at pH 5
CC         and 28 degrees Celsius) {ECO:0000269|PubMed:10975500,
CC         ECO:0000269|PubMed:22004291};
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF149311; AAF03675.1; -; mRNA.
DR   PDB; 3U57; X-ray; 2.43 A; A/B=1-513.
DR   PDB; 3U5U; X-ray; 2.20 A; A/B=1-513.
DR   PDB; 3U5Y; X-ray; 2.30 A; A/B=1-513.
DR   PDB; 3ZJ6; X-ray; 2.40 A; A/B=1-540.
DR   PDB; 4A3Y; X-ray; 2.15 A; A/B=1-540.
DR   PDB; 4ATD; X-ray; 2.10 A; A/B=1-513.
DR   PDB; 4ATL; X-ray; 2.52 A; A/B=1-513.
DR   PDB; 4EK7; X-ray; 2.30 A; A/B=1-513.
DR   PDBsum; 3U57; -.
DR   PDBsum; 3U5U; -.
DR   PDBsum; 3U5Y; -.
DR   PDBsum; 3ZJ6; -.
DR   PDBsum; 4A3Y; -.
DR   PDBsum; 4ATD; -.
DR   PDBsum; 4ATL; -.
DR   PDBsum; 4EK7; -.
DR   AlphaFoldDB; Q9SPP9; -.
DR   SMR; Q9SPP9; -.
DR   CAZy; GH1; Glycoside Hydrolase Family 1.
DR   KEGG; ag:AAF03675; -.
DR   BRENDA; 3.2.1.125; 5309.
DR   GO; GO:0050247; F:raucaffricine beta-glucosidase activity; IDA:UniProtKB.
DR   GO; GO:0050506; F:vomilenine glucosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0009821; P:alkaloid biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   InterPro; IPR001360; Glyco_hydro_1.
DR   InterPro; IPR033132; Glyco_hydro_1_N_CS.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   PANTHER; PTHR10353; PTHR10353; 1.
DR   Pfam; PF00232; Glyco_hydro_1; 1.
DR   PRINTS; PR00131; GLHYDRLASE1.
DR   SUPFAM; SSF51445; SSF51445; 1.
DR   PROSITE; PS00653; GLYCOSYL_HYDROL_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alkaloid metabolism; Direct protein sequencing; Glycosidase;
KW   Hydrolase; Transferase.
FT   CHAIN           1..540
FT                   /note="Raucaffricine-O-beta-D-glucosidase"
FT                   /id="PRO_0000418400"
FT   ACT_SITE        186
FT                   /note="Proton donor"
FT   ACT_SITE        420
FT                   /note="Nucleophile"
FT   BINDING         36
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:22004291"
FT   BINDING         140
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         185..186
FT                   /ligand="substrate"
FT   BINDING         193
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:22004291"
FT   BINDING         347
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         392
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:22004291"
FT   BINDING         420
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:22004291"
FT   BINDING         469
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:22004291"
FT   BINDING         476..477
FT                   /ligand="substrate"
FT   SITE            390
FT                   /note="Directs the conformation of W-392"
FT   SITE            392
FT                   /note="Controls the gate shape and acceptance of
FT                   substrates"
FT   MUTAGEN         186
FT                   /note="E->D,Q: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:22004291"
FT   MUTAGEN         189
FT                   /note="T->A: Reduced activity."
FT                   /evidence="ECO:0000269|PubMed:22004291"
FT   MUTAGEN         193
FT                   /note="H->A: Reduced activity."
FT                   /evidence="ECO:0000269|PubMed:22004291"
FT   MUTAGEN         200
FT                   /note="Y->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:22004291"
FT   MUTAGEN         390
FT                   /note="S->G: Reduced activity."
FT                   /evidence="ECO:0000269|PubMed:22004291"
FT   MUTAGEN         392
FT                   /note="W->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:22004291"
FT   MUTAGEN         420
FT                   /note="E->Q: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:22004291"
FT   MUTAGEN         476
FT                   /note="E->A,L: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:22004291"
FT   MUTAGEN         485
FT                   /note="F->Y: Reduced activity."
FT                   /evidence="ECO:0000269|PubMed:22004291"
FT   HELIX           14..16
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           19..21
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   STRAND          27..31
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           34..37
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           50..57
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           59..61
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           63..65
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   TURN            68..72
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           74..88
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   STRAND          91..96
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           99..102
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           108..110
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           114..129
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   STRAND          133..141
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           145..151
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           153..155
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           159..174
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   TURN            175..177
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   STRAND          180..185
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           187..195
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   TURN            235..237
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           238..260
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           262..265
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   STRAND          268..282
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           286..299
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           301..304
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           306..309
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           314..320
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           321..323
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           329..335
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   STRAND          340..354
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           367..370
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   STRAND          373..376
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   STRAND          378..381
FT                   /evidence="ECO:0007829|PDB:3U5U"
FT   STRAND          382..385
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           398..411
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   STRAND          414..421
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           433..436
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           440..458
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   STRAND          463..469
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           477..479
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   STRAND          482..484
FT                   /evidence="ECO:0007829|PDB:3ZJ6"
FT   STRAND          487..490
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   TURN            492..496
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   STRAND          498..500
FT                   /evidence="ECO:0007829|PDB:4ATD"
FT   HELIX           502..511
FT                   /evidence="ECO:0007829|PDB:4ATD"
SQ   SEQUENCE   540 AA;  60934 MW;  543A24654A4D5E7D CRC64;
     MATQSSAVID SNDATRISRS DFPADFIMGT GSSAYQIEGG ARDGGRGPSI WDTFTHRRPD
     MIRGGTNGDV AVDSYHLYKE DVNILKNLGL DAYRFSISWS RVLPGGRLSG GVNKEGINYY
     NNLIDGLLAN GIKPFVTLFH WDVPQALEDE YGGFLSPRIV DDFCEYAELC FWEFGDRVKH
     WMTLNEPWTF SVHGYATGLY APGRGRTSPE HVNHPTVQHR CSTVAPQCIC STGNPGTEPY
     WVTHHLLLAH AAAVELYKNK FQRGQEGQIG ISHATQWMEP WDENSASDVE AAARALDFML
     GWFMEPITSG DYPKSMKKFV GSRLPKFSPE QSKMLKGSYD FVGLNYYTAS YVTNASTNSS
     GSNNFSYNTD IHVTYETDRN GVPIGPQSGS DWLLIYPEGI RKILVYTKKT YNVPLIYVTE
     NGVDDVKNTN LTLSEARKDS MRLKYLQDHI FNVRQAMNDG VNVKGYFAWS LLDNFEWGEG
     YGVRFGIIHI DYNDNFARYP KDSAVWLMNS FHKNISKLPA VKRSIREDDE EQVSSKRLRK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024